Actively Recruiting
Platino-resistance in Ovarian Cancer
Led by Institut Claudius Regaud · Updated on 2025-11-18
600
Participants Needed
1
Research Sites
677 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Prospective, monocentric study aiming to identify factors involved in platinum based-chemotherapy resistance in patients with epithelial ovarian cancer (all stages). Patients will receive treatment (platinum based-chemotherapy) according to the standard practices. A prospective database and an associated biological collection will be performed during 5 years: * For each patient: clinical, biological, epidemiological and therapeutic treatment data will be collected during the standard therapeutic care. * Biological samples (blood samples, tumor biopsy specimens and ascites samples) will be collected for all patients. These samples will be collected at the same time as those taken in standard practice (no additional biopsy will be performed for the study). Study participation of each patient will be 5 years.
CONDITIONS
Official Title
Platino-resistance in Ovarian Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosis of epithelial ovarian cancer at any stage
- Curative surgery treatment not yet started except for neo-adjuvant treatment
- Planned treatment with platinum-based chemotherapy
- Affiliated with the French social security system
- Provided written informed consent before study procedures
You will not qualify if you...
- Non-epithelial or borderline ovarian tumors
- Recurrent ovarian cancer disease
- Exploratory surgery not performed at Institut Universitaire du Cancer de Toulouse - Oncopole
- Pregnant or breastfeeding women
- Psychological, familial, geographical, or social conditions preventing follow-up or study procedures
- Patients under legal protection or who have lost freedom by legal or administrative decision
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institut Universitaire du Cancer de Toulouse - Oncopole
Toulouse, France
Actively Recruiting
Research Team
G
Gwenaël FERRON
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here